World
Vaccine Makers Race to Create a Booster in 100 Days to Beat Omicron
Variant presented scientists with ‘the list of mutations we never wanted to see,’ Moderna executive says
This article is for subscribers only.
At a plant nestled along a highway 20 miles north of Boston, hundreds of Pfizer Inc. workers are gearing up to produce millions of doses of a new vaccine that looks more and more like the next phase of fighting Covid-19.
Work on the project started the day after Thanksgiving at the 70-acre facility in Andover, Massachusetts, just as the World Health Organization designated a new coronavirus strain, omicron, a variant of concern. The goal of the effort: make a booster shot customized against the highly mutated virus in less than 100 days.